S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
Log in
ETR:ISR

Isra Vision Stock Forecast, Price & News

€47.58
+0.04 (+0.08 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
€47.54
Now: €47.58
€47.70
50-Day Range
€47.10
MA: €47.42
€48.26
52-Week Range
€43.46
Now: €47.58
€50.25
Volume332 shs
Average VolumeN/A
Market Capitalization$1.04 billion
P/E Ratio110.39
Dividend Yield0.38%
BetaN/A
As of June 24, 2020, Isra Vision AG operates as a subsidiary of Atlas Copco AB.
Isra Vision logo

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Software - Application
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone49 6151 948 0
Employees841
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$129.31 million
Cash Flow€1.63 per share
Book Value€9.89 per share

Profitability

Miscellaneous

Market Cap$1.04 billion
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.75 out of 5 stars

Analyst Opinion: 0.5Community Rank: 2.4Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
€47.58
+0.04 (+0.08 %)
(As of 03/2/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ISR News and Ratings via Email

Sign-up to receive the latest news and ratings for ISR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Isra Vision (ETR:ISR) Frequently Asked Questions

Is Isra Vision a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Isra Vision in the last twelve months. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" Isra Vision stock.
View analyst ratings for Isra Vision
or view top-rated stocks.

What stocks does MarketBeat like better than Isra Vision?

Wall Street analysts have given Isra Vision a "Sell" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Isra Vision wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Isra Vision's stock been impacted by Coronavirus?

Isra Vision's stock was trading at €49.70 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ISR stock has decreased by 4.3% and is now trading at €47.58.
View which stocks have been most impacted by COVID-19
.

Is Isra Vision a good dividend stock?

Isra Vision pays an annual dividend of €0.18 per share and currently has a dividend yield of 0.38%. The dividend payout ratio of Isra Vision is 41.76%. This payout ratio is at a healthy, sustainable level, below 75%.
View Isra Vision's dividend history.

What price target have analysts set for ISR?

1 Wall Street analysts have issued 1-year price objectives for Isra Vision's shares. Their forecasts range from €50.00 to €50.00. On average, they expect Isra Vision's share price to reach €50.00 in the next twelve months. This suggests a possible upside of 5.1% from the stock's current price.
View analysts' price targets for Isra Vision
or view top-rated stocks among Wall Street analysts.

Who are Isra Vision's key executives?

Isra Vision's management team includes the following people:
  • Mr. Enis Ersü, Founder, Chairman of Exec. Management Board & CEO
  • Mr. Hans Jürgen Christ, Deputy Chairman of Exec. Management Board & Head of Sales
  • Dr. Johannes Giet, Head of R&D and Member of Exec. Management Board
  • Dr. Frank Meyer, Member of Exec. Management Board
  • Mr. Martin Heinrich, Member of Exec. Management Board
  • Mr. Tomas Lundin, Member of Exec. Management Board

Who are some of Isra Vision's key competitors?

What other stocks do shareholders of Isra Vision own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Isra Vision investors own include Palo Alto Networks (PANW), Alnylam Pharmaceuticals (ALNY), Arcturus Therapeutics (ARCT), Broadcom (AVGO), Alteryx (AYX), Bio-Rad Laboratories (BIO), Compugen (CGEN), Editas Medicine (EDIT), Gilead Sciences (GILD) and Illumina (ILMN).

What is Isra Vision's stock symbol?

Isra Vision trades on the ETR under the ticker symbol "ISR."

What is Isra Vision's stock price today?

One share of ISR stock can currently be purchased for approximately €47.58.

How much money does Isra Vision make?

Isra Vision has a market capitalization of $1.04 billion and generates $129.31 million in revenue each year.

How many employees does Isra Vision have?

Isra Vision employs 841 workers across the globe.

What is Isra Vision's official website?

The official website for Isra Vision is www.isravision.com.

How can I contact Isra Vision?

The company can be reached via phone at 49 6151 948 0.


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.